Pleural Disease Section
-
Making it stick: Rapid pleurodesis for MPE offers faster freedom from IPCs
Rapid pleurodesis combines prompt symptom control with the potential for pleural symphysis in a shorter time frame, allowing for potential lifestyle benefits while minimizing the risk of IPC-related complications.
-
Opening the flood gates: Pleural complications of immune checkpoint inhibitors
The pulmonary and medical oncology community must start to consider pleural complications as a potential risk of immune checkpoint inhibitor therapy.
-
Revival of the aspiration vs chest tube debate for PSP
Considerable heterogeneity exists in the management of primary spontaneous pneumothorax (PSP). American and European guidelines have been grappling with this question for decades: What is the best way to manage […]
-
Primary vs secondary: A review of pneumothorax management
Optimal management of primary spontaneous (PSP) and secondary spontaneous pneumothorax (SSP) remains an area of ongoing debate, with both CHEST and the British Thoracic Society (BTS) offering guidelines to address […]
-
Updated pleural disease guidelines from the British Thoracic Society
After more than a decade, the British Thoracic Society (BTS) released updated guidelines for pleural disease (Roberts ME , et al. Thorax 2023; 78, s1-s42). Their focus includes spontaneous pneumothorax, […]
